Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Key facts

Sponsor

Children's Oncology Group

Principal Investigator

Kimo C. Stine, MD, MD

Arkansas Children's Hospital at the University of Arkansas for Medical Sciences

Intervention

aldesleukin(biological)

Enrollment

1 enrolled

Eligibility

21 years · All sexes

Timeline

1998 – 2005

Study locations (30)

• University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
• University of South Alabama Medical Center, Mobile, Alabama, United States
• MBCCOP - Gulf Coast, Mobile, Alabama, United States
• Arizona Cancer Center, Tucson, Arizona, United States
• Arkansas Children's Hospital, Little Rock, Arkansas, United States
• University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
• University of California San Diego Cancer Center, La Jolla, California, United States
• Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
• Sutter Cancer Center, Sacramento, California, United States
• University of California Davis Medical Center, Sacramento, California, United States
• Kaiser Permanente-Southern California Permanente Medical Group, San Diego, California, United States
• Children's Hospital and Health Center, San Diego, California, United States
• Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States
• Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
• Walter Reed Army Medical Center, Washington D.C., District of Columbia, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute myeloblastic leukemia with maturation

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNCT07060612
  Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA)
  Instituto de Investigacion Sanitaria La Fe

See all trials for Acute myeloblastic leukemia with maturation →